Excellent Delphi-305 discussion from @StephenVLiu reminds us that this is a highly selected patient population. Survival benefit is “profound”. Completely agree.
Post infusion monitoring 1-2hrs in EU, makes this a lot easier to deliver #LCSM #ESMO26